Oesophageal Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed with one of these specific cancers: head and neck cancer, non-small-cell lung cancer, small cell lung cancer, bladder/urinary tract cancer, stomach or stomach-esophagus junction cancer, cervical cancer, esophageal cancer, triple-negative breast cancer, liver cancer, kidney cancer, or colorectal cancer.
• You have already received, or are planned to receive, at least one dose of a type of immunotherapy that targets PD-1 or PD-L1 (a common class of cancer immunotherapy drugs).
• You have had, or will have, a tumor biopsy taken before starting this immunotherapy treatment.
• You have had, or will have, a scan (such as a CT or MRI) of your tumor before starting this immunotherapy treatment.
• You are willing and able to give your consent to take part in the study electronically.
• You can speak, read, and understand English fluently.
• You are 18 years of age or older.
• Enough tissue from your tumor biopsy is available to meet the study's requirements.

Who may not be able to join:

• You are unable or unwilling to give your formal consent to participate.
• Your cancer type is not one of the specific cancers listed above.
• You have already taken part in this same trial before.

Important: Always verify eligibility with the trial site directly before applying.